NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris
Year: 2020
Type: article
Abstract: Candida auris (C. auris) is an emerging pathogenic fungal species that is especially worrisome due to its high mortality rates and widespread antifungal resistance. Previous studies have demonstrated the efficacy of nitric oxide (NO) nanoparticles on Candida species, and, to our knowledge, this is the first study to investigate the antifungal effects of a NO-generating nanoparticle on C. auris. Six C. auris strains were incubated with a nanoparticle (NAC-SNO-np), which releases N-acetylcysteine S-nitrosothiol (NAC-SNO) and N-acetylcysteine (NAC), and generates NO, through colony forming unit (CFU) assays, and confocal laser scanning microscopy. NAC-SNO-np effectively eradicates planktonic and biofilm C. auris. Across all six strains, 10 mg/mL NAC-SNO-np significantly reduced the number of CFUs (p < 0.05) and demonstrated a >70% decrease in biofilm viability (p < 0.05). NAC-SNO-np effectively eradicates planktonic C. auris and significantly reduces C. auris biofilm formation. Hence, this novel NO-releasing nanoparticle shows promise as a future therapeutic.
Source: Journal of Fungi
DOI: 10.3390/jof6020085
Authors: Levi G. Cleare(Data curation, Formal analysis, Investigation, Visualization, Writing – original draft), Kevin L. Li(Data curation, Formal analysis, Investigation, Visualization, Writing – original draft), Waleed M. Abuzeid(Methodology, Supervision, Writing – review & editing), Parimala Nacharaju(Data curation, Formal analysis, Investigation, Methodology, Resources, Visualization, Writing – original draft), Joel M. Friedman(Conceptualization, Methodology, Resources, Supervision, Writing – review & editing), Joshua D. Nosanchuk(Conceptualization, Methodology, Resources, Supervision, Writing – review & editing)
Institutions: Albert Einstein College of Medicine, University of Washington
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,479
OpenAlex ID: W3035722349
